Skip to content
Back to browse
BRAIN Publication-derived

Brain Organoids for Disease Modelling (2023)

Full SOP with Academic or a plan

Source Schafer et al., 2023 · The Salk Institute for Biological Studies, La Jolla, CA · 10.1016/j.cell.2023.04.022

Authors: Simon T. Schafer, Abed A. Mansour, Johannes C.M. Schlachetzki, Monique Pena, Saeed Ghassemzadeh, Lisa Mitchell, Amanda Mar, Daphne Quang, Sarah Stumpf, Irene Santisteban Ortiz, Addison J. Lana, Clara Baek, Raghad Zaghal, Christopher K. Glass, Axel Nimmerjahn, Fred H. Gage Duration: 42 days 6 phases Cell source: Human iPSC, Human ESC, Patient-Derived iPSC (Autism with Macrocephaly)

Abstract

This protocol describes an in vivo xenotransplantation approach to generate immunocompetent human brain organoids (iHBO) containing functionally mature human microglia (hMG) that can be studied within a vascularized, physiologically relevant human brain environment. The transplanted organoids allow investigation of human microglia phenotypes in health and disease, including disease-specific immune responses in patient-derived models of autism with macrocephaly.

Cell source
Human iPSC, Human ESC, Patient-Derived iPSC (Autism with Macrocephaly)
Application
Disease modeling, Developmental study, Neuroimmune interaction research

Protocol overview

28 steps across 6 phases

Phase 1 · Generation of forebrain organoids and fluorescent reporter lines Days 0-42
  1. a Maintenance and lentiviral infection of hESC/iPSC lines
  2. b Initiate forebrain organoid differentiation
  3. c Apply neural induction
  4. d Embed organoids in Matrigel and mature
  5. e Continue organoid maturation and media changes
Phase 2 · Generation and isolation of erythromyeloid progenitors (EMPs) Days 0-16
  1. a Hematopoietic differentiation initiation
  2. b First media change and growth factor supplementation
  3. c Transition to normoxic conditions and second growth factor supplementation
  4. d Harvest and isolate EMPs by FACS
Phase 3 · EMP colonization of forebrain organoids and in vitro co-culture Days 35-42 (organoid age)
  1. a Prepare organoids for EMP co-culture
  2. b Co-culture EMPs with organoids
  3. c Monitor EMP colonization and morphology during in vitro culture
Phase 4 · Surgical transplantation of EMP-containing organoids into mouse brain Day 10 post-EMP integration
  1. a Animal preparation and anesthesia
  2. b Surgical site preparation and craniotomy
  3. c Position and transplant the organoid
  4. d Create cranial window and seal
  5. e Post-operative care
Phase 5 · In vivo characterization of human microglia (weeks 1-24 post-transplantation) Weeks 6-24 post-transplantation
  1. a Immunohistochemical analysis of microglia maturation
  2. b Isolate human microglia for single-cell RNA-sequencing
  3. c Perform single-cell RNA-sequencing
  4. d In vivo two-photon imaging of microglial dynamics
  5. e Induce focal laser lesions and assess microglial response
  6. f Systemic LPS challenge and morphological assessment
Phase 6 · Patient-specific disease modeling: ASD with macrocephaly Days 0-12 weeks post-transplantation
  1. a Generate isogenic iPSC lines from ASD and control subjects
  2. b Generate GFP+ cortical organoids and tdT+ EMPs from subject-derived lines
  3. c Transplant subject-specific iHBOs and assess microglia phenotype
  4. d Generate cross-subject 'sensor' models to establish environment-dependence
  5. e Harvest and analyze subject-specific iHBOs

Full SOP

Full SOPs need an account and a plan

Create an account, then get free Academic access (for verified academics) or choose a plan. Plans include step-by-step procedures, reagent concentrations, QC checklists and batch record templates.

Create an account

Already registered? Log in

Attribution

This SOP was written by Organthis based on the published method in Schafer et al., 2023. Once the originating laboratory has confirmed it, the SOP is marked Verified.

Something wrong with this entry? Report an issue with this protocol

Need a commercial licence?
Use this protocol in your therapeutic or diagnostic pipeline.
Request Commercial Licence